According to Zimmer Biomet's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.36688. At the end of 2023 the company had a P/S ratio of 3.44.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.44 | -10.79% |
2022 | 3.86 | 2.97% |
2021 | 3.74 | -17.65% |
2020 | 4.55 | 17.71% |
2019 | 3.86 | 44.83% |
2018 | 2.67 | -14.75% |
2017 | 3.13 | 16.3% |
2016 | 2.69 | -22.41% |
2015 | 3.47 | -15.82% |
2014 | 4.12 | 20.34% |
2013 | 3.42 | 33.79% |
2012 | 2.56 | 18.98% |
2011 | 2.15 | -13.58% |
2010 | 2.49 | -15.58% |
2009 | 2.95 | 33.81% |
2008 | 2.20 | -44.28% |
2007 | 3.95 | -25.56% |
2006 | 5.31 | 4.41% |
2005 | 5.09 | -22.93% |
2004 | 6.60 | -26.49% |
2003 | 8.98 | 52.01% |
2002 | 5.91 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Edwards Lifesciences EW | 8.88 | 163.82% | ๐บ๐ธ USA |
Stryker Corporation SYK | 6.25 | 85.70% | ๐บ๐ธ USA |
Cooper Companies COO | 4.89 | 45.24% | ๐บ๐ธ USA |
Dentsply Sirona
XRAY | 1.62 | -51.91% | ๐บ๐ธ USA |